Diabetes and kidney dysfunction markedly alter the content of sphingolipids carried by circulating lipoproteins
Samar M. Hammad, Kelly J. Hunt, Nathaniel L. Baker, Richard L. Klein, Maria F. Lopes‐Virella
Topics & Concepts
SphingolipidMedicineDiabetes mellitusInternal medicineType 2 diabetesSphingomyelinEndocrinologyVery low-density lipoproteinLipoproteinCeramideCholesterolBiologyBiochemistryApoptosisSphingolipid Metabolism and SignalingDiabetes, Cardiovascular Risks, and LipoproteinsLysosomal Storage Disorders Research